The company offers loans up to 80 per cent of the value of the pre-owned two-wheeler, with a repayment period of 12 to 24 months. This finance facility is currently available at select pre-owned two wheeler-dealers in Pune.
"We will be focusing on Pune and Nagpur initially and will then target Bengaluru and Chennai markets," Phaneedra Kumar, president, WheelsEMI said in a statement.
"We plan to launch 70 branches across the country in three years and aim to disburse loans of Rs 1,000 crore in the third year with an average ticket size of Rs 35,000," he said. -------------------------------------
State Bank of India today announced pilot launch of a distribution alliance with Cox & Kings for sale of travel prepaid cards in the country.
This partnership will help marketing of travel prepaid card available in eight currencies and will currently target the corporate customers of the bank.
"This has been the third alliance SBI has entered into for travel card business to supplement their distribution reach which is already very deep in the consumer segment," SBI's DMD (digital banking and new business) Manju Agarwal said.
--------------------------------------- Fullerton India gets Rs 200 crore capital from parent
The capital infusion will primarily support future business growth of Fullerton India's housing finance arm - Grihashakti.
"We now have an ambitious growth agenda, and this infusion reinforces Fullerton Financial Holdings' commitment to the Indian market and, for us, lays the foundation for the execution of our ambitious growth plans," Fullerton India's head (business strategy and execution) Anand Natarajan said. ---------------------------------------- nexGTv acquires global broadcast rights for 170 BBC videos
Subscription-led video entertainment app nexGTv today said it has acquired from BBC World Service India the global broadcast rights of over 170 videos produced by BBC Hindi and BBC Tamil.
----------------------------
Sayre Therapeutics inks agreement with Spanish firm GP Pharm
Healthcare company, Sayre Therapeutics today announced that it has entered into agreement with Spanish company GP Pharm SA for launching EMA approved differentiated Leuprolide acetate depot formulation in South Asia.
"We have entered into an exclusive license agreement with GP Pharm SA to distribute, market and sell Lutrate depot in 1 and 3 month formulations in India, Sri Lanka, Bangladesh and Nepal. GP Pharm will supply Lutrate to Sayre on an exclusive basis from its manufacturing facility in Barcelona, Spain," a statement issued here said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
